Taken together, these findings indicated that ApoA-1 protein might decrease the CTC level by preventing CTC formation, affecting the survival, and inducing apoptosis of tumor cells in circulation, which resulted in higher recurrence rates and poor outcomes in HCC patients with low serum ApoA-1 levels. Here, APOA1 is linked to neoplasm.